Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes-Reference-Cited by-同舟云学术

Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes

Published:2021-07-16 Issue:10 Volume:23 Page:2344-2353
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Quast Daniel R.¹^ORCID,Nauck Michael A.¹^ORCID,Schenker Nina¹,Menge Björn A.¹,Kapitza Christoph²^ORCID,Meier Juris J.¹³^ORCID

Affiliation:

1. Diabetes Division, Department of Internal Medicine St. Josef Hospital, Ruhr‐University Bochum Bochum Germany

2. Profil Institut für Stoffwechselforschung Neuss Germany

3. Department of Internal Medicine Gastroenterology and Diabetes, Augusta Clinic Bochum Bochum Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14477

Reference48 articles.

1. GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans

2. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon‐like peptide‐1 (GLP‐1)‐(7‐36) amide in type 2 (noninsulin‐dependent) diabetic patients;Willms B;J Clin Endocrinol Metab.,1996

3. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes

4. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

5. Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective Study;Cureus;2024-09-11

2. Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs;Obesity Pillars;2024-09

3. Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events;Frontiers in Pharmacology;2024-07-08

4. Safe Continuation of Glucagon-like Peptide 1 Receptor Agonists at Endoscopy: A Case Series of 57 Adults Undergoing Endoscopic Sleeve Gastroplasty;Obesity Surgery;2024-05-16

5. Correlation between intestinal flora and GLP-1 receptor agonist dulaglutide in type 2 diabetes mellitus treatment—A preliminary longitudinal study;iScience;2024-05